USPTO serial 75283262
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
ELAN PHARMA INTERNATIONAL LIMITED
CO. WESTMEATH, IE
County Westmeath, IE
County Westmeath, IE
County Westmeath, IE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele M. Simkin and Norm J. Rich
Michele M. Simkin and Norm J. Rich Foley & Lardner LLP3000 K Street, N.W., Sixth FloorWASHINGTON, DC 20007-5143UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | tablet matrix used to improve the solubility and absorption characteristics of poorly water soluble drugs sold as an integral component of various oral pharmaceuticals, namely, antacids, antispasmodics and anti-ulcerants, laxatives, anti-diarrhoeals, colorectal agents, cardiac drugs, drugs for the treatment of disorders of the central nervous system, cns stimulants, analgesics, antipyretics and anti-infammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, desensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, pharmaceutical preparations for the treatment of dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells, and medical diagnostic reagents, for administration to humans | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 1, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 23, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 26, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 29, 2021 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jun 27, 2019 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 16, 2013 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 17, 2012 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 5, 2011 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| May 4, 2010 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| May 4, 2010 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| May 4, 2010 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 3, 2010 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Feb 3, 2010 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 20, 2009 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 16, 2009 | FAXX | FAX RECEIVED | — |
| Nov 12, 2009 | REIN | REINSTATED | — |
| Oct 23, 2009 | FAXX | FAX RECEIVED | — |
| Oct 23, 2009 | FAXX | FAX RECEIVED | — |
| Oct 16, 2009 | FAXX | FAX RECEIVED | — |
| Mar 31, 2007 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 18, 2006 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Jun 26, 2006 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Jun 26, 2006 | PAPER RECEIVED | — | |
| Mar 24, 2006 | CFIT | CASE FILE IN TICRS | — |
| Jun 27, 2000 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 4, 2000 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 3, 2000 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 30, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 1999 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Nov 4, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 1999 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jun 11, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 14, 1998 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jun 29, 1998 | CNSL | LETTER OF SUSPENSION MAILED | — |
| May 28, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 1997 | DOCK | ASSIGNED TO EXAMINER | — |